knowledge -WSS

knowledge

author：leisure time 2025-10-01 23:01:46 - browse：1

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Flagship Pioneering startup Sonata Therapeutics lays off 21

Wikipedia

WSS

Congress must reauthorize a committee to support older Americans

As AI regulations shape up, health tech startups beg for clarity

Abridge raises $150m as clinical notes automation market heats up

In 'major milestone,' FDA approves first cell therapy for solid tumors

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Wegovy, Zepbound and weight loss drugs that preserve muscle

hotspot

knowledge

explore

Cancer drug shortages should be causing more outrage

Secretariat’s lessons for human medicine

Supreme Court strikes down use of affirmative action

Surge of respiratory disease in China has likely explanation

BioMarin wins approval for gene therapy to treat hemophilia A

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Hepatitis C has a cure — but many Americans still lack access to it

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Bright Health sells Medicare Advantage business to Molina

Reporting on presidential health from Reagan to Trump and Biden

explore

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Why medical students are struggling with mental health

Congress may force more Covid

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Researchers tackle phage therapy hurdles for wider adoption

Childhood cancer progress stalls for Black, Hispanic kids: Report

hotspot

leisure time

Wikipedia

Wikipedia